Arcus Biosciences (RCUS) Treasury Shares (2017 - 2025)

Arcus Biosciences' Treasury Shares history runs 9 years deep, the most recent figure standing at $2.9 million for Q4 2025.

• On a quarterly basis, Treasury Shares rose 31.82% year-over-year to $2.9 million in Q4 2025; TTM through Dec 2025 was $2.9 million, a 31.82% increase from a year earlier, with the FY2025 full-year figure at $2.9 million, up 31.82% from the prior year.
• Treasury Shares advanced to $2.9 million in Q4 2025 per RCUS's latest filing, from $2.2 million in the prior quarter.
• Across five years, Treasury Shares topped out at $2.9 million in Q4 2025 and bottomed at $1.1 million in Q4 2021.
• The 5-year median for Treasury Shares is $1.5 million (2023), against an average of $1.8 million.
• Across the five-year window, Treasury Shares surged 48.92% in 2021 and grew 15.38% in 2023, its largest moves.
• Year by year, Treasury Shares stood at $1.1 million in 2021, then increased by 18.18% to $1.3 million in 2022, then gained by 15.38% to $1.5 million in 2023, then surged by 46.67% to $2.2 million in 2024, then jumped by 31.82% to $2.9 million in 2025.
• Per Business Quant, the three latest RCUS Treasury Shares figures stand at $2.9 million (Q4 2025), $2.2 million (Q4 2024), and $1.5 million (Q4 2023).